Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis

被引：16

作者：

Distler, O. ^{[1
]}

Behrens, F.

Huscher, D.

Foeldvari, I.

Zink, A.

Nash, P.

Denton, C. P.

Humbert, M.

Matucci-Cerinic, M.

Seibold, J.

Rubin, L.

Furst, D. E.

机构：

[1] Univ Zurich Hosp, Dept Rheumatol, CH-8091 Zurich, Switzerland

[2] Goethe Univ Frankfurt, ZAFES, Div Rheumatol, D-6000 Frankfurt, Germany

[3] German Rheumatism Res Ctr, Berlin, Germany

[4] Rheumatol Res Unit, Sunshine Coast, Qld, Australia

[5] UCL Royal Free & Univ Coll, Sch Med, Ctr Rheumatol, London, England

[6] Univ Paris Sud, Hop Antoine Beclere, Ctr Malad Vasc Pulm, Serv Pneumol & Reanimat Resp, Clamart, France

[7] Univ Terapia Med I, Florence, Italy

[8] Univ Michigan, Scleroderma Program, Ann Arbor, MI 48109 USA

[9] Univ Calif San Diego, Sch Med, Div Pulm & Crit Care Med, La Jolla, CA 92093 USA

[10] Univ Calif Los Angeles, David Geffen Sch, Dept Med, Div Rheumatol, Los Angeles, CA USA

来源：

RHEUMATOLOGY | 2006年 / 45卷 / 12期

关键词：

D O I：

10.1093/rheumatology/kel273

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1455 / 1457

页数：3

共 25 条

[1] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial [J].

Badesch, DB ;

Tapson, VF ;

McGoon, MD ;

Brundage, BH ;

Rubin, LJ ;

Wigley, FM ;

Rich, S ;

Barst, RJ ;

Barrett, PS ;

Kral, KM ;

Jöbsis, MM ;

Loyd, JE ;

Murali, S ;

Frost, A ;

Girgis, R ;

Bourge, RC ;

Ralph, DD ;

Elliott, CG ;

Hill, NS ;

Langleben, D ;

Schilz, RJ ;

McLaughlin, VV ;

Robbins, IM ;

Groves, BM ;

Shapiro, S ;

Medsger, TA ;

Gaine, SP ;

Horn, E ;

Decker, JC ;

Knobil, K .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :425-+

[2] Sitaxsentan therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

Langleben, D ;

Frost, A ;

Horn, EM ;

Oudiz, R ;

Shapiro, S ;

McLaughlin, V ;

Hill, N ;

Tapson, VF ;

Robbins, IM ;

Zwicke, D ;

Duncan, B ;

Dixon, RAF ;

Frumkin, LR .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (04) :441-447

[3] Beraprost therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

McGoon, M ;

McLaughlin, V ;

Tapson, V ;

Oudiz, R ;

Shapiro, S ;

Robbins, IM ;

Channick, R ;

Badesch, D ;

Rayburn, BK ;

Flinchbaugh, R ;

Sigman, J ;

Arneson, C ;

Jeffs, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2119-2125

[4]

Bellamy N, 1999, J RHEUMATOL, V26, P948

[5]

Boers M, 1998, J RHEUMATOL, V25, P198

[6]

Channick R., 2001, Journal of Heart and Lung Transplantation, V20, P262, DOI 10.1016/S1053-2498(00)00606-9

[7] Ambrisentan therapy for pulmonary arterial hypertension [J].

Galié, N ;

Badesch, D ;

Oudiz, R ;

Simonneau, G ;

McGoon, MD ;

Keogh, AM ;

Frost, AE ;

Zwicke, D ;

Naeije, R ;

Shapiro, S ;

Olschewski, H ;

Rubin, LJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (03) :529-535

[8] Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension [J].

Galiè, N ;

Seeger, W ;

Naeije, R ;

Simonneau, G ;

Rubin, LJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :81S-88S

[9] Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension:: With pulmonary arterial hypertension:: A randomized, double-blind, placebo-controlled trial [J].

Galiè, N ;

Humbert, M ;

Vachiéry, JL ;

Vizza, CD ;

Kneussl, M ;

Manes, A ;

Sitbon, O ;

Torbicki, A ;

Delcroix, M ;

Naeije, R ;

Hoeper, M ;

Chaouat, A ;

Morand, S ;

Besse, B ;

Simonneau, G .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (09) :1496-1502

[10] Sildenafil citrate therapy for pulmonary arterial hypertension [J].

Galiè, N ;

Ghofrani, HA ;

Torbicki, A ;

Barst, RJ ;

Rubin, LJ ;

Badesch, D ;

Fleming, T ;

Parpia, T ;

Burgess, G ;

Branzi, A ;

Grimminger, F ;

Kurzyna, M ;

Simonneau, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2148-2157

← 1 2 3 →